The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mollinedo, F.
Right arrow Articles by Flores, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollinedo, F.
Right arrow Articles by Flores, I.

The Journal of Immunology, Vol 153, Issue 6 2457-2469, Copyright © 1994 by American Association of Immunologists


ARTICLES

Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells

F Mollinedo, C Gajate and I Flores
Center for Biological Research, Superior Council of Scientific Research, Madrid, Spain.

The induction of the AP-1 transcription factor has been ascribed to the early events leading to T lymphocyte activation. We have examined the possibility that stimulation of phospholipase D (PLD) may regulate activation of transcription factor AP-1 in human T cells by transfecting human T lymphocyte Jurkat cells with a plasmid containing an AP-1 enhancer element and a chloramphenicol acetyltransferase reporter gene. We have detected activatable PLD in Jurkat cells, and we have found that addition of phosphatidic acid (PA), the physiologic product of PLD action on phospholipids, is rapidly incorporated into Jurkat cells and leads to activation of transcription factor AP-1. Treatment of Jurkat cells with anti-CD3 mAb activated both PLD and transcription factor AP-1. Wortmannin, an inhibitor of receptor-coupled PLD activation, blocked the anti-CD3-induced increases in both PLD activity and AP-1 enhancer activity. We found a good correlation in the transfected cells between PLD activation and induction of AP-1 enhancer activity under different experimental conditions. Furthermore, ethanol, an inhibitor of the PLD pathway, blocked the anti-CD3-stimulated AP-1 enhancer activity. However, this anti-CD3-mediated response was not inhibited by neomycin, an inhibitor of phosphoinositide hydrolysis. The increases in AP-1 enhancer activity induced by PA or anti-CD3 mAb were efficiently abrogated by the presence of propranolol, an inhibitor of PA phosphohydrolase and protein kinase C (PKC). Furthermore, the PA- and the anti-CD3-induced increases in AP-1 enhancer activity were blocked by the presence of PKC inhibitors or by PKC down-regulation. These data indicate that PLD stimulation can activate the transcription factor AP-1 in T lymphocytes, and suggest that the induction of AP-1 enhancer factor activity by PA is mediated via PKC stimulation, either through a direct activating effect of PA or through PA-derived diacylglycerol formation. These data also provide evidence for a role of PLD-derived lipids in the induction of AP-1 enhancer activity resulting from stimulation of the TCR/CD3 complex, suggesting that increased PLD activity can play an important role in T lymphocyte activation.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. J. Cummings, N. L. Parinandi, A. Zaiman, L. Wang, P. V. Usatyuk, J. G. N. Garcia, and V. Natarajan
Phospholipase D Activation by Sphingosine 1-Phosphate Regulates Interleukin-8 Secretion in Human Bronchial Epithelial Cells
J. Biol. Chem., August 9, 2002; 277(33): 30227 - 30235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Schwartz, H. Ehland, V. L. Sylvia, D. Larsson, R. R. Hardin, V. Bingham, D. Lopez, D. D. Dean, and B. D. Boyan
1{alpha},25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase
Endocrinology, July 1, 2002; 143(7): 2775 - 2786.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Schwartz, V. L. Sylvia, D. Larsson, I. Nemere, D. Casasola, D. D. Dean, and B. D. Boyan
1alpha ,25(OH)2D3 Regulates Chondrocyte Matrix Vesicle Protein Kinase C (PKC) Directly via G-protein-dependent Mechanisms and Indirectly via Incorporation of PKC during Matrix Vesicle Biogenesis
J. Biol. Chem., March 29, 2002; 277(14): 11828 - 11837.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. O. Ebinu, S. L. Stang, C. Teixeira, D. A. Bottorff, J. Hooton, P. M. Blumberg, M. Barry, R. C. Bleakley, H. L. Ostergaard, and J. C. Stone
RasGRP links T-cell receptor signaling to Ras
Blood, May 15, 2000; 95(10): 3199 - 3203.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kasai, K. Ohguchi, S. Nakashima, Y. Ito, T. Naganawa, N. Kondo, and Y. Nozawa
Increased Activity of Oleate-Dependent Type Phospholipase D During Actinomycin D-Induced Apoptosis in Jurkat T Cells
J. Immunol., December 15, 1998; 161(12): 6469 - 6474.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. M. Steed, K. L. Clark, W. C. Boyar, and D. J. Lasala
Characterization of human PLD2 and the analysis of PLD isoform splice variants
FASEB J, October 1, 1998; 12(13): 1309 - 1317.
[Abstract] [Full Text]


Home page
FASEB J.Home page
M. Pouliot, C. Gilbert, P. Borgeat, P. E. Poubelle, S. Bourgoin, C. Créminon, J. Maclouf, S. R. Mccoll, and P. H. Naccache
Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils
FASEB J, September 1, 1998; 12(12): 1109 - 1123.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley
Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Gajate, A. Santos-Beneit, M. Modolell, and F. Mollinedo
Involvement of c-Jun NH2-Terminal Kinase Activation and c-Jun in the Induction of Apoptosis by the Ether Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
Mol. Pharmacol., April 1, 1998; 53(4): 602 - 612.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. B. Bacon, T. J. Schall, and D. J. Dairaghi
RANTES Activation of Phospholipase D in Jurkat T Cells: Requirement of GTP-Binding Proteins ARF and RhoA
J. Immunol., February 15, 1998; 160(4): 1894 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-R. Nofer, M. Tepel, M. Walter, U. Seedorf, G. Assmann, and W. Zidek
Phosphatidylcholine-specific Phospholipase C Regulates Thapsigargin-induced Calcium Influx in Human Lymphocytes
J. Biol. Chem., December 26, 1997; 272(52): 32861 - 32868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. G. Choudhury, C. Karamitsos, J. Hernandez, A. Gentilini, J. Bardgette, and H. E. Abboud
PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF
Am J Physiol Renal Physiol, December 1, 1997; 273(6): F931 - F938.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.